ADC Therapeutics SA (ADCT)

Last Closing Price: 3.09 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ADC Therapeutics SA (ADCT) had Net Income of $-157.85M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$70.84M
Net Income
$-157.85M
$5.95M
$64.89M
$201.49M
$-130.65M
$-25.48M
$-156.14M
$-156.14M
$-156.30M
$-157.85M
$-157.85M
$-156.30M
$-130.65M
$-127.38M
97.16M
97.16M
$-1.62
$-1.62
Balance Sheet Financials
$307.39M
$5.08M
$14.59M
$321.98M
$80.47M
$113.63M
$444.15M
$524.62M
$-202.64M
$-202.64M
$-202.64M
98.86M
Cash Flow Statement Financials
$-123.83M
$-0.87M
$97.05M
$278.60M
$250.87M
$-27.73M
$6.57M
--
--
Fundamental Metrics & Ratios
3.82
--
--
-1.28
-0.56
91.60%
-184.44%
-184.44%
-179.82%
-220.42%
-222.83%
$-124.70M
--
--
--
0.22
0.32
3.49
104.68
77.89%
77.89%
-49.02%
177.34%
$-2.05
$-1.28
$-1.27